Estimaciones de analistas de Wall Street para Nano-X Imaging Ltd. (NNOX): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Ratios de valoración
| Precio / Valor contable | 0.46 |
| EV / EBITDA | -0.43 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | 0 | $1.3M | $8.6M | $9.9M | $11.3M | $13.0M |
| Coste de Ventas | $35000 | $53000 | $208000 | $2.8M | $15.5M | $16.5M | $21.9M | $25.8M |
| Beneficio Bruto | -$35000 | -$53000 | -$208000 | -$1.5M | -$6.9M | -$6.6M | -$10.6M | -$12.8M |
| I+D | $672000 | $2.7M | $9.2M | $17.1M | $26.5M | $26.0M | $20.2M | $19.2M |
| Generales y Administrativos | $1.2M | $19.9M | $34.7M | $41.7M | $45.6M | $28.4M | $25.7M | $27.1M |
| Gastos Operativos | $1.9M | $22.6M | $43.9M | $60.0M | $72.3M | $56.0M | $46.1M | $47.9M |
| Beneficio Operativo | -$1.9M | -$22.6M | -$43.9M | -$61.6M | -$109.7M | -$62.6M | -$56.7M | -$60.7M |
| EBITDA | -$1.9M | -$22.5M | -$43.6M | -$59.3M | -$75.7M | -$47.7M | -$45.0M | -$49.0M |
| Gastos por Intereses | $5000 | 0 | 0 | $288000 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$1.9M | -$22.6M | -$43.8M | -$61.8M | -$108.9M | -$61.1M | -$53.9M | -$76.8M |
| Impuestos | $5000 | 0 | 0 | -$48000 | -$3.7M | -$339000 | -$358000 | -$1.8M |
| Beneficio Neto | -$1.9M | -$22.6M | -$43.5M | -$61.8M | -$105.2M | -$60.8M | -$53.5M | -$75.0M |
| BPA | $-0.06 | $-0.49 | $-1.22 | $-1.28 | $-2.01 | $-1.08 | $-0.91 | $-1.16 |
| BPA Diluido | $-0.06 | $-0.49 | $-1.22 | $-1.28 | $-2.01 | $-1.08 | $-0.91 | $-1.16 |
| Acciones en Circulación (Diluidas) | $34.2M | $45.7M | $35.7M | $48.2M | $52.2M | $56.4M | $58.6M | $64.8M |
Precio
| Precio | $0.75 |
| Capitalización | $52M |
| Bolsa | NASDAQ |
| País | IL |
Empresas relacionadas: CATX · HCAT · HSDT · INGN · MXCT · OM · PROF
Explorar sector: Healthcare · Medical - Devices
Más secciones de NNOX: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones